These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Association between colony forming units-granulocyte macrophage expression of Ia-like (HLA-DR) antigen and control of granulocyte and macrophage production. A new role for prostaglandin E. Pelus LM. J Clin Invest; 1982 Sep; 70(3):568-78. PubMed ID: 6286727 [Abstract] [Full Text] [Related]
4. Relationship between HLA-DR expression by normal myeloid progenitor cells and inhibition of colony growth by prostaglandin E. Implications for prostaglandin E resistance in chronic myeloid leukemia. Cannistra SA, Herrmann F, Davis R, Nichols K, Griffin JD. J Clin Invest; 1986 Jan; 77(1):13-20. PubMed ID: 3455931 [Abstract] [Full Text] [Related]
5. Relationship of cell-cycle expression of Ia-like antigenic determinants on normal and leukemia human granulocyte-macrophage progenitor cells to regulation in vitro by acidic isoferritins. Broxmeyer HE. J Clin Invest; 1982 Mar; 69(3):632-42. PubMed ID: 6174548 [Abstract] [Full Text] [Related]
6. Prostaglandin-E-mediated modulation of human marrow CFU-GM Ia-antigen expression: kinetics and specificity. Pelus LM. Exp Hematol; 1984 Dec; 12(11):831-7. PubMed ID: 6210207 [Abstract] [Full Text] [Related]
7. Antigenic characteristics of circulating CFU-GM in chronic granulocytic leukaemia resemble those of CFU-GM in normal marrow and differ from those in normal blood. Robak T, Nolasco I, Hibbin J, Goldman JM. Leuk Res; 1985 Dec; 9(8):1023-9. PubMed ID: 2413317 [Abstract] [Full Text] [Related]
8. Modulation of the expression of HLA-DR (Ia) antigens and the proliferation of human erythroid (BFU-E) and multipotential (CFU-GEMM) progenitor cells by prostaglandin E. Lu L, Pelus LM, Broxmeyer HE. Exp Hematol; 1984 Oct; 12(9):741-8. PubMed ID: 6436046 [Abstract] [Full Text] [Related]
9. Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1. Pelus LM, Broxmeyer HE, Clarkson BD, Moore MA. Cancer Res; 1980 Jul; 40(7):2512-5. PubMed ID: 6930324 [Abstract] [Full Text] [Related]
10. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY. J Immunol; 1986 Jun 15; 136(12):4487-95. PubMed ID: 3086433 [Abstract] [Full Text] [Related]
11. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors. Aglietta M, Piacibello W, Stacchini A, Dezza L, Sanavio F, Malavasi F, Infelise V, Resegotti L, Gavosto F. Cancer Res; 1986 Apr 15; 46(4 Pt 1):1783-7. PubMed ID: 3456268 [Abstract] [Full Text] [Related]
13. Granulocyte/macrophage progenitor cells from peripheral blood and bone marrow differ in their response to prostaglandin E1. Richman CM, Johnson GD. Blood; 1987 Dec 15; 70(6):1792-6. PubMed ID: 3499944 [Abstract] [Full Text] [Related]
15. Expression of Ia-like antigens defined by monoclonal OKIal antibody of hemopoietic progenitor cells in cord blood: a comparison with human bone marrow. Koizumi S, Yamagami M, Miura M, Horita S, Sano M, Ikuta N, Taniguchi N. Blood; 1982 Oct 15; 60(4):1046-9. PubMed ID: 6956374 [Abstract] [Full Text] [Related]